World's Best Scientists 2026 revealed!
Gérard Le Fur

Gérard Le Fur

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
20822
World Ranking
7288
National Ranking
239

Overview

Gérard Le Fur is affiliated with Sanofi in France. The professional focuses on research within the pharmaceutical sector as part of this prominent global company.

Aspects of their scholarly output, such as co-authors, main fields and subfields of study, frequent publication venues, and specific topics covered, are not listed. Likewise, no recent papers or book publications have been recorded in the available data.

No information about awards or honors received by Gérard Le Fur has been documented. The scientist is currently living, and no details regarding their career timeline or other biographical data are provided.

Best Publications

  • SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

    Murielle Rinaldi-Carmona;Francis Barth;Michel Héaulme;David Shire

  • Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.

    Sylvaine Galiègue;Sophie Mary;Jean Marchand;Danielle Dussossoy

  • A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 EVIDENCE FOR A NEW MODEL OF RECEPTOR/LIGAND INTERACTIONS

    Monsif Bouaboula;Sylvie Perrachon;Laura Milligan;Xavier Canat

  • In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

    Xavier Emonds-Alt;Jean-Daniel Doutremepuich;Michel Heaulme;Gervais Neliat

  • Cannabinoid‐receptor expression in human leukocytes

    Monsif Bouaboula;Murielle Rinaldi;Pierre Carayon;Christine Carillon

  • The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

    Omar Jbilo;Christine Ravinet-Trillou;Michèle Arnone;Isabelle Buisson

  • An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.

    David Shire;Christine Carillon;Mourad Kaghad;Bernard Calandra

  • Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

    Magali Gary-Bobo;Ghizlane Elachouri;Jean François Gallas;Philip Janiak

  • Blockade of CRF 1 or V 1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

    R Alonso;G Griebel;G Pavone;J Stemmelin

  • Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

    Monsif Bouaboula;Caroline Poinot-Chazel;Jean Marchand;Xavier Canat

  • Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

    Murielle Rinaldi-Carmona;Francis Barth;Michel Héaulme;Richard Alonso

  • Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

    Natalio Vita;Patrick Laurent;Sylvie Lefort;Pascale Chalon

  • Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation

    Monsif Bouaboula;Sandrine Hilairet;Jean Marchand;Lluis Fajas

  • Molecular cloning of a levocabastine-sensitive neurotensin binding site

    Pascale Chalon;Natalio Vita;Mourad Kaghad;Marie Guillemot

  • Characterization of (2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

    Claudine Serradeil-Le Gal;Jean Wagnon;Jacques Simiand;Guy Griebel

  • Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor

    David Shire;Bernard Calandra;Murielle Rinaldi-Carmona;Didier Oustric

  • Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716.

    Sandrine Hilairet;Monsif Bouaboula;Dominique Carrière;Gérard Le Fur

  • Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.

    Monsif Bouaboula;Bernard Bourrié;Murielle Rinaldi-Carmona;David Shire

  • The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes.

    Magali Gary-Bobo;Ghizlane Elachouri;Bernard Scatton;Gérard Le Fur

  • Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

    Vincent Santucci;Jean Jacques Storme;Philippe Soubrie;Gerard Le Fur

Frequent Co-Authors

Philippe Soubrié
Philippe Soubrié Collège de France
Pierre Casellas
Pierre Casellas Sanofi (France)
Pascual Ferrara
Pascual Ferrara Institut Pasteur
Daniel Caput
Daniel Caput Novartis (United States)
Bernard Scatton
Bernard Scatton Club for Internet and Society Enthusiasts
Guy Griebel
Guy Griebel Sanofi (France)
Keith Wesnes
Keith Wesnes University of Exeter
William Rostène
William Rostène Institut de la Vision
David Warburton
David Warburton University of Southern California
Hubert Vidal
Hubert Vidal Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gérard Le Fur